Brief: Castle Biosciences Q2 Net Income USD 8.92 Million Vs. IBES Estimate USD -9.23 Million
05/08/2024 21:05
Aug 05 (Reuters) - Castle Biosciences Q2 operating expenses USD 81.99 million. * Q2 pretax profit USD 7.886 million vs. IBES estimate USD -9.29 million * Q2 revenue USD 87.002 million vs. IBES estimate USD 69.3 million * Q2 operating income USD 5.012 million
Recent news on Castle Biosciences
See all newsBrief: Castle Biosciences, - Opens New Laboratory And Office Facility In Scottsdale, Arizona
U.S. RESEARCH ROUNDUP-Abbvie, Amazon, Illumina
Castle Biosciences Inc reports results for the quarter ended June 30 - Earnings Summary
Castle Biosciences beats Q2 revenue estimates, hikes forecast
Brief: Castle Biosciences Q2 Revenue USD 103.546 Million Vs. IBES Estimate USD 86.2 Million